TRIMTECH Therapeutics
Develops therapeutics focused on neurodegenerative diseases, with seed funding supporting research from its Cambridge base.
Overview
TRIMTECH Therapeutics is a Cambridge-based biotechnology company working on therapeutics for neurodegenerative diseases. Its target market includes patients, clinicians and research partners focused on conditions involving progressive neurological decline. The company is categorized here as Deep Tech rather than AI because the disclosed round information describes neurodegenerative disease therapeutics, not AI software or infrastructure. It announced a seed financing round in June 2026, with the provided funding context citing $14 million raised and a headline referencing seed funding brought to €41 million.
Funding History
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work
Frequently Asked Questions
- How much funding does AI Funding track for TRIMTECH Therapeutics?
- AI Funding tracks $14M for TRIMTECH Therapeutics across 1 funding round in this database.
- Who are TRIMTECH Therapeutics's investors?
- TRIMTECH Therapeutics's investors include Johnson & Johnson Innovation – JJDC, Inc., BGF, Cambridge Innovation Capital, Dementia Discovery Fund.
- What does TRIMTECH Therapeutics do?
- TRIMTECH Therapeutics is a Cambridge-based biotechnology company working on therapeutics for neurodegenerative diseases. Its target market includes patients, clinicians and research partners focused on conditions involving progressive neurological decline. The company is categorized here as Deep Tech rather than AI because the disclosed round information describes neurodegenerative disease therapeutics, not AI software or infrastructure. It announced a seed financing round in June 2026, with the provided funding context citing $14 million raised and a headline referencing seed funding brought to €41 million.
- Where is TRIMTECH Therapeutics headquartered?
- TRIMTECH Therapeutics is headquartered in Cambridge, United Kingdom.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.